Weiss and colleagues demonstrated that oligodendrogliomas reliably occur in mice doubly transgenic for an S100β promoter driven-v-erbB (a transforming EGF-R allele), and either INK4a-ARF +/- or P53 +/- heterozygosity [24]. The gene discussed is CDKN2A; the disease is oligodendroglioma.